These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25393073)

  • 21. Diagnosing and treating cannabinoid hyperemesis.
    Wilson O; Lutton S; Doherty K
    Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cannabinoid hyperemesis syndromecan be relieved by hot showers].
    Søndermølle MB; Randers E
    Ugeskr Laeger; 2021 Apr; 183(15):. PubMed ID: 33913422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
    Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
    West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
    Rosenthal J; Howell M; Earl V; Malik M
    Am J Med; 2021 Dec; 134(12):e582-e583. PubMed ID: 34343506
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
    Hernandez JM; Paty J; Price IM
    CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report.
    Andrews KH; Bracero LA
    J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
    Brown JM; Wilsey MJ; Dhana L; Lonsdale H
    J Psychiatr Pract; 2023 Sep; 29(5):354-358. PubMed ID: 37678364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Cannabinoid Hyperemesis With Olanzapine: A Case Series.
    Hsu J; Herrmann Z; Kashyap S; Claassen C
    J Psychiatr Pract; 2021 Jul; 27(4):316-321. PubMed ID: 34398582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
    Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
    Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
    Dosani K; Koletic C; Alhosh R
    Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 35. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
    Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report.
    Richards JR; Dutczak O
    J Clin Psychopharmacol; 2017 Aug; 37(4):482-484. PubMed ID: 28604421
    [No Abstract]   [Full Text] [Related]  

  • 37. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
    Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
    Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paediatric cannabinoid hyperemesis.
    Lonsdale H; Wilsey MJ
    Curr Opin Pediatr; 2022 Oct; 34(5):510-515. PubMed ID: 35946907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain.
    Shahsavari D; Reznick-Lipina K; Malik Z; Weiner M; Jehangir A; Repanshek ZD; Parkman HP
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00362. PubMed ID: 34060494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.
    Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N
    Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.